laboratori
method
detect
respiratori
virus
allow
identif
also
exclus
specif
etiolog
underli
given
pathogen
state
respiratori
system
complement
support
clinic
diagnosi
provid
basi
clinic
decis
make
treatment
also
use
epidemiolog
studi
like
virus
respiratori
virus
detect
one
combin
three
major
viral
detect
method
direct
detect
viru
genet
materi
protein
cultur
viru
suitabl
host
cell
line
assess
presenc
effect
host
cell
line
serolog
evid
infect
organ
direct
detect
method
includ
detect
whole
virus
electron
microscopi
detect
inclus
bodi
light
microscopi
addit
viru
detect
mean
specif
antibodi
antigen
either
bodi
fluid
cultur
host
cell
polymeras
chain
reaction
pcr
seem
power
molecular
biolog
techniqu
use
detect
viral
genet
materi
directli
recent
develop
techniqu
realtim
pcr
also
allow
calcul
number
copi
viru
present
given
biolog
sampl
cultur
respiratori
viru
host
allow
direct
detect
describ
earlier
indirect
detect
base
biolog
effect
may
trigger
host
thu
respiratori
virus
detect
titrat
cytopath
effect
cpe
trigger
cultur
cell
exampl
orthomyxovirus
paramyxovirus
influenza
parainfluenza
detect
abil
trigger
erythrocyt
aggreg
hemagglutin
serolog
studi
use
mani
way
viru
detect
one
approach
presenc
specif
antibodi
organ
lead
inhibit
biolog
effect
stock
viral
solut
elicit
target
cell
eg
inhibit
hemagglutin
addit
abil
assess
immunoglobulin
igm
specif
antibodi
patient
blood
acut
phase
chang
immunoglobulin
g
igg
antibodi
titer
acut
phase
convalesc
valuabl
tool
identifi
ongo
viral
infect
case
discrimin
recurr
latent
infect
viral
agent
tropism
respiratori
system
infect
produc
symptom
upper
lower
airway
although
frequent
mention
hundr
differ
virus
produc
respiratori
symptom
due
larg
number
picornaviru
adenoviru
serotyp
small
differ
clinic
present
serotyp
seven
eight
type
agent
describ
separ
includ
newli
identifi
sever
acut
respiratori
syndrom
sar
coronavirus
also
recent
identifi
human
metapneumoviru
mpv
preval
pathogen
microorgan
probabl
human
rv
common
cold
virus
belong
picornaviru
small
rna
famili
also
includ
enterovirus
polioviru
echoviru
coxsacki
viru
cardioviru
aphthoviru
rv
serotyp
identifi
number
divid
major
serotyp
minor
group
former
use
intercellular
adhes
cellular
receptor
wherea
latter
use
lowdens
lipoprotein
receptor
epidemiolog
rvinduc
cold
close
relat
social
contact
peak
usual
seen
children
return
school
vacat
period
one
promin
role
rv
trigger
asthma
exacerb
compar
titrat
nasal
pharyng
oral
secret
shown
replic
activ
nose
howev
studi
compar
nasal
throat
swab
sputum
sampl
obtain
asthma
exacerb
show
viral
isol
rate
higher
sputum
suggest
rv
may
also
replic
lower
airway
later
clearli
demonstr
use
molecular
biologybas
detect
techniqu
although
sever
upper
respiratori
tract
symptom
rv
infect
differ
patient
asthma
normal
subject
durat
sever
lower
respiratori
tract
symptom
pronounc
patient
asthma
lower
respiratori
tract
epitheli
cell
infect
rv
rich
sourc
inflammatori
mediat
may
trigger
propag
airway
inflamm
obstruct
respiratori
syncyti
viru
belong
pneumovirina
subfamili
mediums
nm
rna
viru
variat
attach
glycoprotein
viral
envelop
give
rise
two
antigen
distinct
strain
rsv
b
although
conflict
data
major
studi
report
strain
common
produc
sever
diseas
wide
rang
speci
experiment
infect
human
rsv
natur
infect
speciesspecif
rsv
enter
bodi
eye
nose
lesser
extent
mouth
viru
subsequ
spread
along
airway
mucosa
mostli
celltocel
transfer
along
intracytoplasm
bridg
also
aspir
upper
lower
airway
rsv
follow
wellcharacter
epidemiolog
pattern
yearli
outbreak
occur
octob
may
temper
climat
least
half
infant
popul
becom
infect
first
rsv
epidem
almost
children
infect
year
age
although
infect
usual
lead
mild
respiratori
ill
infant
sever
diseas
bronchiol
characterist
clinic
manifest
complic
evid
hospit
bronchiol
consider
increas
recent
decad
hospit
children
increas
probabl
wheez
later
life
immun
statu
host
probabl
play
import
role
process
relationship
rsv
infect
atopi
subsequ
symptom
develop
asthma
discuss
detail
chapter
three
type
influenza
virus
design
b
c
belong
orthomyxovirus
identifi
negativestrand
segment
rna
virus
two
influenza
envelop
glycoprotein
hemagglutinin
neuraminidas
determin
viral
entri
target
cell
bind
sialic
acid
fuse
cellular
membran
element
releas
viru
infect
influenza
viru
occur
inspir
contamin
droplet
infect
person
infect
cell
becom
round
swollen
pyknot
nuclei
edema
polymorphonuclear
infiltr
seen
surround
tissu
progress
chang
epitheli
cell
suggest
infect
start
trachea
ascend
descend
epidemiolog
influenza
virus
character
yearli
epidem
last
week
late
winter
year
usual
one
domin
type
subtyp
ill
initi
appear
children
wherea
later
epidem
adult
affect
virus
present
commun
epidem
caus
ill
low
frequenc
antigen
variat
readili
occur
h
n
primari
structur
give
rise
new
subtyp
antigen
shift
intrasubtyp
chang
antigen
drift
type
influenza
virus
associ
pandem
occur
everi
year
last
potenti
pandem
strain
emerg
record
avian
origin
current
circul
type
human
isol
subtyp
avian
isol
subtyp
abl
transmit
infect
human
enter
cell
differ
cellular
receptor
human
parainfluenza
virus
piv
includ
four
member
number
belong
paramyxovirida
subfamili
togeth
mump
measl
piv
distinct
epidemiolog
clinic
characterist
well
differ
age
distribut
pattern
piv
piv
member
respiroviru
genu
gener
associ
laryngotracheobronch
croup
upper
respiratori
tract
ill
pharyng
wherea
piv
member
rubulaviru
genu
also
major
caus
infant
bronchiol
associ
develop
pneumonia
suscept
subject
piv
rare
less
well
studi
piv
occur
biennial
epidem
autumn
coincid
croup
outbreak
peak
incid
occur
children
year
age
piv
epidem
less
predict
howev
less
follow
biennial
pattern
piv
affect
mostli
children
younger
year
age
piv
uniqu
among
piv
propens
infect
infant
younger
month
age
spring
epidem
piv
infect
frequent
occur
yearli
peak
seen
spring
summer
infect
initi
attach
viru
host
cell
interact
viral
h
n
glycoprotein
cellular
sialic
acid
receptor
follow
uncoat
viru
transloc
cytoplasm
transcript
lead
replic
transmiss
aerosol
spread
consid
import
although
deposit
surfac
subsequ
selfinocul
may
also
relev
viru
replic
occur
throughout
tracheobronchi
tree
caus
local
inflamm
howev
mild
rapidli
repair
focal
tissu
destruct
observ
vivo
howev
immunocompromis
host
fatal
giant
cell
pneumonia
may
develop
central
pathogenesi
piv
infect
abil
virus
escap
interferonmedi
immun
respons
contrast
rest
respiratori
virus
adenovirus
deoxyribonucl
acid
dna
virus
larg
famili
virus
includ
six
subgenera
serotyp
overal
size
nm
virion
nake
contain
kb
doublestrand
dna
encod
polypeptid
strand
protein
allow
effici
endosom
lysi
escap
lead
genom
entranc
host
cell
nucleu
propens
adenovirus
shut
express
host
messeng
rna
induc
excess
synthesi
adenovir
protein
lead
accumul
protein
intranuclear
bodi
incompat
normal
cell
function
upper
airway
epitheli
cell
ciliari
microtubular
abnorm
lead
defect
mucociliari
clearanc
import
featur
adenoviru
abil
persist
host
long
time
lowgrad
replic
even
longer
period
product
adenovir
protein
without
replic
complet
viru
human
coronavirus
isol
major
hcv
studi
date
relat
one
two
refer
strain
design
differ
extens
recent
coronaviru
isol
infant
bronchiol
conjunct
share
sequenc
ident
sever
promin
differ
indic
new
group
coronaviru
human
aminopeptidas
n
present
lung
intestin
kidney
epitheli
cell
identifi
receptor
bind
major
histocompat
complex
class
molecul
viral
replic
demonstr
nasal
mucosa
induc
inflamm
ciliari
damag
epitheli
cell
shed
vivo
cpe
pronounc
case
rv
infect
hcv
replic
lower
airway
confirm
volunt
success
infect
intranas
inocul
hcv
caus
approxim
common
cold
diseas
gener
mild
evid
hcvinduc
cold
may
caus
milder
lower
respiratori
tract
symptom
virus
howev
report
sever
lower
respiratori
tract
involv
young
children
elderli
recent
eastern
asiabas
sar
epidem
attribut
new
coronaviru
share
limit
homolog
known
coronavirus
viru
caus
diffus
alveolar
damag
interstiti
infiltr
day
fever
nonproduct
cough
may
progress
breathless
hypoxemia
patient
seriou
infect
character
mortal
rate
even
high
patient
older
year
age
consid
children
ill
much
mild
see
chapter
although
sarscov
coronaviru
differ
phylogenet
known
hcv
evid
deriv
character
coronaviru
addit
sequenc
isol
show
number
distinct
featur
genom
eg
sever
small
open
read
frame
gene
potenti
biolog
signific
final
new
respiratori
viru
mpv
recent
isol
nasopharyng
aspir
young
children
netherland
later
shown
present
worldwid
mpv
first
human
respiratori
pathogen
classifi
member
metapneumoviru
genu
new
viru
prove
paramyxoviruslik
pleomorph
particl
electron
microscopi
phylogenet
analys
show
sequenc
variat
isol
exist
two
potenti
genet
cluster
mpv
clinic
symptom
children
viru
isol
netherland
rang
upper
respiratori
airway
diseas
sever
bronchiol
pneumonia
subsequ
studi
conduct
differ
locat
use
mix
patient
popul
variou
respiratori
symptom
establish
associ
viru
acut
respiratori
ill
upper
lower
tract
age
group
diagnost
techniqu
viru
cultur
major
prerequisit
success
applic
detect
method
appropri
collect
transport
mainten
clinic
sampl
gener
sampl
collect
first
day
symptom
lead
higher
recoveri
rate
virus
upper
respiratori
sampl
includ
nasopharyng
oropharyng
swab
former
provid
lower
rate
contamin
lower
respiratori
compon
swab
place
viral
transport
medium
cultur
use
prepar
slide
immunofluoresc
detect
either
roll
swab
directli
slide
recoveri
cell
centrifug
nasopharyng
aspir
npa
consid
better
sourc
viral
isol
swab
although
induc
sputum
often
contamin
oropharyng
compon
microbi
agent
hinder
viral
recoveri
easili
obtain
sampl
least
older
children
success
rate
greater
therefor
often
use
either
filter
membran
filter
dilut
usual
presenc
reduc
agent
dithiothreitol
reduc
viscos
transtrach
aspir
bronchial
biopsi
specimen
bronchial
wash
sampl
consid
better
sourc
sputum
cultur
direct
immunodetect
virus
pellet
cell
similarli
centrifug
mild
condit
g
supernat
pellet
bronchoalveolar
lavag
provid
good
sourc
isol
immunofluoresc
detect
respiratori
virus
howev
invas
procedur
preclud
routin
use
children
detail
descript
issu
beyond
scope
chapter
varieti
comprehens
articl
avail
within
textbook
elsewher
respiratori
viru
number
cell
line
strain
allow
replic
vitro
tabl
suscept
cell
cultur
may
undergo
degen
process
exposur
respiratori
virus
common
cpe
pattern
includ
syncytia
format
fusion
mani
cell
multinucl
structur
vacuol
gener
larg
bubblelik
region
cytoplasm
granular
degener
round
detach
also
common
featur
fig
dose
caus
cpe
inocul
well
tcid
use
express
content
given
viral
prepar
titer
cell
monolay
permit
grow
cover
solid
agar
medium
foci
virusinfect
cell
form
plaqu
may
abl
stain
specif
dye
eg
neutral
red
manner
differ
uninfect
cell
thu
readili
identifi
count
virus
also
plaquepurifi
techniqu
virus
possess
hemagglutinin
eg
influenza
parainfluenza
virus
may
abl
adher
erythrocyt
host
cell
replic
suspens
erythrocyt
deriv
suitabl
speci
ad
infect
cell
cultur
adher
clump
certain
period
reveal
viru
rotat
enhanc
yield
effect
cpe
cultiv
viru
liposom
agent
ad
media
well
centrifug
protocol
may
increas
detect
rate
addit
viru
isol
cultur
cell
deriv
biopsi
sampl
although
cocultur
helper
cell
often
lead
higher
recoveri
rate
techniqu
overcom
viral
inhibitori
activ
certain
tissu
homogen
cell
cultur
use
two
addit
way
identif
respiratori
virus
first
sera
patient
assess
abil
inhibit
cpe
plaqu
format
hemadsorpt
activ
normal
trigger
stock
viral
solut
known
infect
convers
viru
strain
isol
patient
expos
specif
immun
sera
known
prevent
activ
final
result
assess
cell
cultur
although
cell
cultur
remain
mani
case
gold
standard
achiev
highest
sensit
score
detect
sever
virus
major
disadvantag
rather
timeconsum
process
demand
sever
day
even
week
result
obtain
obvious
unaccept
clinic
practic
particular
whenev
decis
alter
antivir
treatment
must
made
recent
rapid
protocol
use
combin
cell
cultur
anoth
detect
method
immunofluoresc
electron
microscopi
pcrbase
method
develop
techniqu
rather
monitor
appear
cpe
sampl
inocul
onto
cultur
presenc
replic
viru
verifi
hour
second
method
mixtur
cell
line
also
use
improv
detect
rate
interest
recent
advanc
influenzasuscept
minklungderiv
cell
human
adenocarcinoma
cell
line
use
combin
detect
respiratori
virus
cocultur
two
cell
line
shell
vial
shown
detect
respiratori
virus
synergist
greater
sensit
singl
cultur
rmix
monolay
use
directli
cryopreserv
vial
inocul
coverslip
clinic
sampl
vial
centrifug
g
minut
serumfre
medium
ad
hour
later
coverslip
remov
stain
mixtur
antisera
mani
respiratori
virus
posit
signal
present
cell
parallel
coverslip
dispers
onto
suitabl
chamber
contain
multipl
coverslip
examin
separ
presenc
individu
respiratori
virus
use
monoclon
antibodi
use
method
definit
result
posit
neg
obtain
within
day
wherea
convent
singlecellcultur
cpe
observ
final
result
take
approxim
day
moreov
posit
result
obtain
day
earlier
method
although
similar
sensit
convent
cell
cultur
direct
immunofluoresc
respect
respiratori
virus
influenza
parainfluenza
rsv
method
less
sensit
detect
adenoviru
rv
test
far
fertil
egg
use
cultur
respiratori
virus
influenza
inocul
amniot
caviti
use
mainli
isol
virus
clinic
sampl
harvest
usual
conduct
hour
inocul
egg
previous
chill
prevent
releas
red
blood
cell
would
lead
loss
viru
due
absorpt
cell
inocul
suscept
anim
common
practic
detect
mani
virus
recent
sar
epidem
instanc
one
first
crucial
test
identifi
viru
intracrani
intraperiton
inject
clinic
sampl
suckl
mice
observ
mice
day
patholog
find
exampl
includ
adv
serotyp
given
intraven
adult
mice
kill
within
day
wherea
adenovirus
administ
subcutan
newborn
hamster
caus
death
within
day
nasopharyng
aspir
lavag
well
lung
biopsi
specimen
suitabl
materi
detect
respiratori
virus
electron
microscopi
typic
protocol
grid
place
drop
sampl
minut
drain
filter
paper
grid
stain
fluid
sampl
place
support
film
grid
film
made
polyvinyl
formal
ethylen
dichlorid
formvar
solut
mechan
stronger
collodion
film
solut
isoamyl
acet
film
cast
glass
slide
experienc
personnel
grid
made
press
grid
onto
film
slide
appropri
presenc
water
silvergray
rather
charcoalgray
gold
color
coincid
optim
film
thick
addit
carbon
coat
vacuum
facilit
spread
sampl
improv
result
glow
discharg
vacuum
treatment
grid
suitabl
agent
eg
polyllysin
alcian
blue
cytochrom
c
bovin
serum
albumin
commonli
use
overcom
spread
problem
viral
transport
medium
ad
npa
bronchoalveolar
lavag
specimen
electron
microscopi
includ
salt
protein
may
obscur
electron
microscopi
field
addit
dilut
particl
contrast
concentr
particl
contain
lavag
npa
sampl
recommend
achiev
ultracentrifug
ultrafiltr
agar
diffus
agar
diffus
drop
suspens
place
top
agar
allow
diffus
freeli
end
procedur
liquid
salt
diffus
agar
leav
filmcoat
grid
contain
viru
drain
filter
paper
stain
electron
microscopi
pseudoreplica
techniqu
variat
agar
diffus
method
wherebi
drop
allow
diffus
agar
irradi
cover
formvar
film
formvar
membran
care
remov
allow
float
onto
water
surfac
grid
appli
replica
membran
pick
aid
filter
paper
antibodi
also
use
concentr
virus
suspens
clump
well
attach
onto
grid
aggreg
sampl
incub
antiserum
centrifug
place
onto
grid
pseudoreplica
techniqu
altern
antiserum
mix
agar
grid
place
onto
gel
viru
suspens
ad
allow
absorb
follow
remov
stain
grid
solidphas
immunoelectron
microscopi
film
coat
antibodi
incub
viru
suspens
immunoprecipit
techniqu
particularli
help
picornavirus
detect
virus
small
sometim
appear
similar
lipid
droplet
addit
techniqu
allow
specif
identif
viru
biolog
fluid
provid
viral
etiolog
pathogen
state
investig
suspect
known
howev
virus
tend
clump
absenc
antiserum
reduc
specif
procedur
virus
suspens
grid
incub
primari
antiserum
allow
aggreg
antibodi
wash
prepar
treat
colloid
goldlabel
secondari
antibodi
gold
label
use
specif
detect
immun
complex
serum
well
subvir
particl
somewhat
differ
approach
virus
expos
excess
antibodi
result
extens
coat
rather
aggreg
virus
method
allow
specif
identif
serotyp
virus
serv
assess
reactiv
convalesc
serum
known
virus
final
shortterm
cultur
viru
vitro
possibl
harvest
appear
cpe
good
altern
enrich
sampl
contain
unaccept
low
number
viral
particl
electron
microscopi
adenovirus
paramyxovirus
belong
group
virus
detect
supernat
massiv
cpe
occur
hand
adenoviru
membraneassoci
may
lost
remov
debri
centrifug
addit
problem
npa
specimen
presenc
mucu
inhibit
spread
sampl
specimen
treat
equal
volum
buffer
contain
appropri
dithiothreitol
concentr
break
mucu
specimen
place
glutaraldehyd
cacodyl
phosphat
buffer
store
refriger
c
rather
frozen
maintain
tissu
architectur
specif
local
viru
osmium
fixat
oso
acid
hepe
piperazin
diethanesulfon
acid
pipe
base
buffer
also
use
en
bloc
stain
conduct
uranyl
acet
veron
buffer
otherwis
dehydr
embed
resin
follow
fixat
step
although
optim
formalinfix
materi
paraffinembed
section
also
use
electron
microscopi
circumst
suitabl
treatment
sampl
area
use
electron
microscopi
limit
wise
first
stain
section
suitabl
stain
toluidin
blue
select
area
particular
interest
eg
cpe
trim
section
thin
section
virus
also
seen
extract
solid
tissu
suitabl
buffer
homogen
repeat
freez
thaw
treatment
liquid
sampl
thin
section
also
method
choic
identif
viru
cell
cultur
viru
trigger
cell
lysi
detect
cell
supernat
medium
ultracentrifug
perform
remov
debri
follow
neg
stain
pellet
cell
also
embed
agar
treat
tissu
block
electron
microscopi
liquid
sampl
contain
respiratori
virus
aim
identifi
particl
base
morpholog
characterist
tabl
picornavirus
adenovirus
two
type
respiratori
virus
nake
virion
icosahedr
symmetri
round
appear
electron
microscopi
contrast
adenovirus
higher
size
rang
among
nake
virion
picornavirus
small
often
confus
tailless
bacteriophag
speci
avail
immunoprecipit
techniqu
use
case
clump
coat
concentr
spheric
structur
prerequisit
given
sampl
character
posit
addit
adenovirus
degener
individu
capsom
may
appear
separ
form
hexagon
lattic
adenovirus
also
resembl
herpesvirus
appear
differenti
may
base
larger
size
latter
envelop
respiratori
virus
influenza
virus
parainfluenza
virus
coronavirus
soft
membran
becom
deform
dri
neg
stain
thu
particl
may
appear
pleomorph
may
vari
size
envelop
respiratori
virus
spike
rather
smooth
coronavirus
long
spike
surfac
wherea
paramyxovirus
orthomyxovirus
contain
project
appear
fring
outer
side
howev
even
form
sometim
confus
mitochondria
invert
bacteri
membran
debri
final
major
problem
orthomyxoviru
paramyxoviru
famili
similar
electron
microscop
appear
addit
inform
usual
requir
discrimin
anoth
featur
may
facilit
identif
particular
respiratori
viru
appear
nucleocapsid
structur
present
envelop
virus
contain
nucleic
acid
viral
protein
spheric
helic
complex
parainfluenza
virus
instanc
helic
filament
nucleocapsid
inform
obtain
electron
microscop
studi
thin
section
solid
tissu
limit
appear
viral
particl
cellular
locat
also
provid
import
evid
properti
instanc
virus
replic
nucleu
dna
virus
wherea
rna
virus
replic
cytoplasm
nake
virus
adenovirus
caus
cell
lysi
seen
round
shell
core
differ
densiti
surround
dead
cell
cytopatholog
advanc
adenovirus
may
seen
nucleu
cytoplasm
picornavirus
caus
swell
endoplasm
reticulum
ribosom
may
appear
larg
bead
string
envelop
virus
acquir
membran
bud
nuclear
envelop
plasma
membran
vesicl
within
cell
difficulti
discrimin
virion
normal
cell
organel
lysosom
golgi
complex
howev
virus
spike
appear
thicker
membran
cellular
compart
size
shape
nucleocapsid
also
import
thin
section
spheric
nucleocapsid
round
appear
resembl
small
nake
virion
wherea
acquir
filament
helic
shape
thin
elong
structur
seen
go
plane
section
adenovirus
discrimin
otherwis
similar
herpesvirus
smaller
size
nucleocapsid
transmiss
electron
microscopi
method
refer
identif
measur
mani
virus
eg
use
immedi
indic
outbreak
recent
sar
epidem
howev
need
special
expens
instrument
skill
technician
fact
facilit
use
smaller
laboratori
moreov
unabl
discrimin
among
virus
famili
among
particular
subtyp
mani
case
addit
method
fluoresc
necessari
overcom
obstacl
addit
distinguish
infecti
noninfecti
particl
contrast
culturebas
method
howev
even
one
viru
particl
identifi
sampl
wherea
method
eg
antigen
detect
requir
greater
number
viral
element
fluoresc
dye
use
stain
purifi
viru
prepar
allow
enumer
viru
solut
oligreen
instanc
dye
specif
bind
nucleotid
success
use
enumer
adenoviru
rsv
influenza
method
perform
within
hour
end
densitygradientpurifi
viru
prepar
incub
dye
subject
analysi
modifi
flow
cytomet
although
yet
test
clinic
sampl
method
provid
inform
genom
size
viru
measur
consist
data
obtain
transmiss
electron
microscopi
enumer
viral
stock
antigenbas
detect
method
respiratori
virus
presuppos
knowledg
suspicion
particular
viru
present
sampl
preclud
discoveri
unknown
virus
howev
method
rapid
accur
featur
major
import
surveil
control
epidem
diseas
eg
influenza
rsv
viral
antigen
reveal
base
abil
antigen
interact
antibodi
elicit
specif
immun
respons
addit
specif
function
assay
hemagglutin
test
assess
presenc
particular
protein
found
envelop
orthomyxovirus
paramyxovirus
conduct
reveal
respect
viru
describ
section
serolog
method
sputum
nasal
aspir
consid
better
throat
swab
detect
virus
rsv
influenza
method
immunofluoresc
base
chemic
conjug
fluorochrom
antibodi
without
compromis
either
abil
fluorochrom
fluoresc
specif
antibodi
fluorescein
isothiocyan
tetramethyl
rhodamin
isothiocyan
wide
use
fluorochrom
former
fluoresc
yellowishgreen
wherea
latter
appear
reddishorang
fluorescein
isothiocyan
seem
suitabl
clinic
sampl
background
often
red
green
addit
redfluoresc
dye
congo
red
use
stain
cellular
compon
red
provid
contrast
green
fluoresc
fluorescein
isothiocyan
fluoresc
microscop
requir
detect
light
emit
excit
fluorochrom
modern
fluoresc
microscop
epiillumin
system
light
select
wavelength
deflect
object
top
surfac
sampl
result
emit
light
direct
object
dichroic
mirror
barrier
filter
ocular
observ
fluorochrom
specif
fluoresc
characterist
instanc
fluorescein
isothiocyan
absorpt
nm
emiss
nm
avail
interfer
filter
fluoresc
microscop
transmit
light
nm
ie
visibl
part
spectrum
practic
first
sampl
fix
onto
slide
thereaft
incub
either
specif
antibodi
conjug
fluorochrom
direct
detect
primari
specif
antibodi
thereaft
secondari
antibodi
rais
primari
one
conjug
fluorochrom
indirect
detect
first
method
less
sensit
avoid
nonspecif
stain
neg
sampl
often
seen
indirect
method
howev
gener
primari
conjug
mani
virus
labori
costli
wherea
secondari
conjug
may
common
sever
antigen
incub
time
short
procedur
minut
make
immunofluoresc
advantag
method
rapid
viru
detect
viral
sampl
also
detect
immunofluoresc
spin
cultur
wherebi
suitabl
cell
monolay
grown
coverslip
within
flatbottom
vial
sampl
appli
top
coverslip
vial
centrifug
g
minut
techniqu
facilit
viru
entri
target
cell
hour
later
longer
depend
viru
coverslip
remov
fix
stain
immunofluoresc
direct
indirect
immunofluoresc
use
develop
number
rapid
test
detect
respiratori
virus
accomplish
within
minut
becom
popular
due
rapid
eas
perform
usual
spot
slide
contain
sampl
prepar
everi
viru
test
cytospun
incub
monoclon
antibodi
recent
advanc
singl
spot
use
simultan
detect
seven
respiratori
virus
rsv
influenza
b
adenoviru
parainfluenza
virus
rhodamin
label
use
rsv
antibodi
system
wherea
fluorescein
use
case
thu
develop
reddishgold
color
spot
suggest
presenc
rsv
particl
sampl
wherea
green
color
fluorescein
follow
second
reaction
anoth
spot
determin
virus
present
sensit
method
greatli
enhanc
centrifug
superior
enzym
immunoassay
eia
base
protocol
inferior
cell
cultur
studi
anoth
indirect
fluoresc
method
prove
effici
cell
cultur
detect
respiratori
virus
nasopharyng
swab
two
type
radioimmunoassay
ria
competit
ria
method
known
quantiti
radioactivitylabel
antigen
compet
unlabel
antigen
ad
test
sampl
inhibit
bind
label
antigen
depend
concentr
unlabel
antigen
clinic
sampl
label
antigen
final
bound
antibodi
measur
refer
bound
antigen
wherea
unconjug
label
antigen
refer
free
antigen
circumv
problem
aris
separ
bound
free
antigen
solidphas
ria
immunoreact
use
first
antibodi
antigen
immobil
solid
support
step
unwant
reactant
remov
readili
wash
contrast
labori
expens
gener
label
viral
antigen
mani
labil
noncompetit
ria
method
use
label
antibodi
instead
viral
antigen
former
stabl
predict
structur
biochem
properti
noncompetit
ria
therefor
popular
diagnost
virolog
techniqu
known
sandwich
ria
unlabel
viral
antibodi
adsorb
solidphas
support
allow
captur
viral
antigen
present
clinic
sampl
radiolabel
antibodi
indic
antibodi
allow
bind
captur
viral
antigen
procedur
either
direct
indirect
latter
case
primari
unlabel
indic
antibodi
use
initi
follow
incub
secondari
radiolabel
antibodi
procedur
free
antibodi
remov
final
incub
bound
antibodi
measur
nasal
aspir
suitabl
sourc
assess
presenc
respiratori
virus
rsv
ria
direct
detect
virus
tissu
cell
cultur
ilabel
viral
antibodi
incub
cell
monolay
tissu
section
unbound
label
antibodi
remov
bound
radioact
measur
radioact
bound
infect
tissu
cultur
compar
radioact
bound
uninfect
control
sampl
ratio
exceed
consid
posit
indirect
version
techniqu
sampl
first
incub
unlabel
antibodi
follow
ilabel
secondari
antibodi
indic
name
eia
base
conjug
suitabl
enzym
eg
horseradish
peroxidas
alkalin
phosphatas
antibodi
subsequ
use
qualit
quantit
detect
antigen
enzymelabel
antibodi
coupl
substrat
give
insolubl
color
product
use
detect
viral
antigen
directli
indirectli
tissu
cell
cultur
cytoimmunoenzymat
stain
color
substrat
observ
nake
eye
light
microscopi
even
electron
microscopi
case
electrondens
product
immunofluoresc
method
describ
earlier
infect
control
cell
monolay
tissu
section
slide
fix
incub
directli
enzymecoupl
antibodi
uncoupl
primari
enzymecoupl
secondari
antibodi
indirect
approach
unbound
enzym
conjug
remov
wash
slide
incub
enzym
substrat
develop
color
product
slide
rins
counterstain
mount
mount
medium
observ
light
microscop
modif
indirect
approach
includ
addit
step
wherebi
antibodi
rais
enzym
incub
sampl
antibodi
also
conjug
enzym
sensit
greatli
enhanc
peroxidaseantiperoxidas
alkalin
phosphataseantialkalin
phosphatas
use
final
reaction
product
either
solubl
color
complex
insolubl
substrat
observ
nake
eye
observ
light
microscop
measur
spectrophotomet
typic
peroxidaseantiperoxidas
protocol
sampl
control
incub
rabbit
antivir
antibodi
subsequ
secondari
antibodi
rais
differ
speci
eg
sheep
goat
subsequ
sampl
incub
peroxidaseantiperoxidas
rais
rabbit
final
substrat
follow
stop
reaction
avidinbiotin
anoth
system
wide
use
increas
sensit
approach
bind
reaction
two
molecul
strong
occur
independ
immun
reaction
assay
typic
avidinbiotin
complex
protocol
biotinconjug
primari
antibodi
incub
sampl
unbound
antibodi
wash
enzymeconjug
avidin
streptavidin
ad
complex
form
monitor
final
addit
substrat
mount
slide
indirect
approach
unlabel
primari
antibodi
first
incub
sampl
follow
secondari
incub
biotinyl
antibodi
biotinavidin
enzym
complex
incub
assess
presenc
viral
antigen
quantit
heterogen
eia
assay
use
enzymat
activ
independ
interact
antigen
enzymeconjug
antibodi
vice
versa
enzymeconjug
antigen
use
end
unbound
enzymelabel
antibodi
remov
incub
rel
long
like
viral
ria
assay
quantit
eia
use
unlabel
antivir
antibodi
bound
solid
phase
eg
microtit
plate
cuvett
unbound
antibodi
remov
adsorpt
nonspecif
bind
site
block
block
agent
bovin
serum
albumin
sampl
ad
unbound
materi
remov
enzymeconjug
antibodi
ad
antibodi
bind
antigen
captur
solidphas
bound
antibodi
remov
unbound
materi
enzym
substrat
ad
format
reaction
product
measur
measur
reflect
amount
enzym
bound
antigen
retain
solid
phase
control
sampl
alway
includ
defin
background
level
modif
influenza
adenoviru
rsv
measur
method
cassett
eia
method
base
fact
larg
amount
antibodi
bound
nitrocellulos
nylon
membran
membran
attach
plastic
well
entir
system
attach
cassett
contain
materi
absorb
wast
fluid
gener
assay
antibodi
control
dot
slot
onto
membran
separ
well
method
offer
advantag
increas
sensit
reduc
time
requir
complet
base
principl
numer
variat
use
differ
sensit
score
solid
phase
instanc
substitut
bead
coat
antibodi
incub
sampl
bead
transfer
membran
assay
go
standard
eia
altern
classic
dotblot
apparatu
use
place
antibodi
dot
membran
addit
bind
site
membran
block
sampl
control
ad
serial
dilut
quantit
wast
fluid
collect
associ
vacuum
system
howev
system
although
abl
discrimin
serotyp
speci
eg
influenza
vs
b
may
sensit
cell
cultur
direct
immunofluoresc
detect
viru
timeresolv
fluoroimmunoassay
unusu
long
fluoresc
decay
time
lanthanid
element
europium
eu
use
discrimin
fluoresc
decay
characterist
europiumconjug
antibodi
background
fluoresc
decay
clinic
sampl
europium
first
chelat
ethylenediaminetetraacet
acid
conjug
antibodi
repres
protocol
microtit
plate
strip
coat
antibodi
remain
bind
site
plate
block
clinic
sampl
ad
simultan
europiumconjug
antibodi
incub
unbound
materi
wash
adenoviru
rsv
influenza
viru
parainfluenza
viru
detect
timeresolv
fluoroimmunoassay
howev
report
limit
sensit
method
detect
respiratori
virus
clinic
sampl
optic
immunoassay
recent
advanc
field
antigen
detect
optic
immunoassay
technolog
allow
direct
visual
detect
macromolecul
bound
onto
molecular
thin
film
bind
result
increas
thick
optic
surfac
silicon
wafer
film
alter
reflect
light
path
perceiv
color
chang
observ
nake
eye
practic
viralspecif
antibodi
immobil
surfac
allow
captur
extract
viral
antigen
place
directli
onto
surfac
incub
room
temperatur
short
period
addit
suitabl
substrat
posit
result
appear
color
spot
wherea
absenc
antigen
sampl
background
color
remain
unchang
commerci
avail
test
influenza
viru
rsv
take
littl
minut
complet
requir
sophist
laboratori
equip
provid
obviou
advantag
influenzaspecif
optic
immunoassay
test
report
good
cell
cultur
detect
influenza
b
clinic
sampl
howev
other
found
low
sensit
score
method
compar
obtain
direct
fluoresc
cell
cultur
latex
agglutin
assay
antibodyco
nanoparticl
polystyren
polyacrylamid
latex
agaros
bead
colloid
gold
agglutin
presenc
viral
antigen
typic
protocol
respiratori
virus
clarifi
dilut
npa
sampl
mix
antibodyco
latex
particl
microscop
slide
agglutin
reaction
readili
observ
usual
minut
although
method
simpl
rapid
usual
character
low
sensit
mani
control
clinic
sampl
show
nonspecif
agglutin
indic
name
serolog
method
attempt
detect
virus
host
assess
presenc
specif
antibodi
blood
sampl
case
cours
ill
blood
sampl
collect
least
twice
acut
phase
convalesc
comparison
antibodi
pattern
two
state
allow
safe
demonstr
diagnost
signific
activ
viru
acutephas
blood
collect
soon
possibl
onset
diseas
later
week
wherea
convalesc
sampl
collect
least
week
onset
requir
make
serolog
test
relev
epidemiolog
studi
clinic
use
long
delay
definit
diagnosi
made
limit
use
urgent
decis
make
clinic
practic
howev
mani
case
rapid
method
antigen
detect
ineffici
eg
rsv
detect
adult
serolog
test
consid
refer
method
moreov
remain
method
choic
archiv
materi
exampl
sensit
pcr
detect
influenza
infect
among
five
class
human
immunoglobulin
igg
igm
iga
ige
igd
four
igg
subclass
longer
halflif
day
other
associ
longterm
protect
addit
igg
antibodi
exert
protect
role
infect
trigger
complement
fixat
improv
specif
immun
respons
bind
surfac
cytotox
effector
cell
virus
induc
mainli
respons
igm
antibodi
repres
approxim
one
tenth
serum
immunoglobulin
first
produc
exposur
foreign
antigen
secretori
iga
constitut
first
line
defens
mucos
viral
infect
first
encount
foreign
antigen
igm
class
antibodi
primarili
produc
wherea
igg
may
produc
subsequ
may
domin
later
phase
respons
repeat
encount
memori
b
cell
produc
high
level
highaffin
igg
antibodi
antigen
local
mucosa
immun
respons
driven
b
cell
interstiti
lymphoid
follicl
eg
tonsil
peyer
patch
also
produc
high
quantiti
iga
mani
potenti
antigen
viru
may
present
differ
time
point
cours
infect
primari
antibodi
respons
viru
typic
character
earli
onset
igm
product
peak
week
declin
later
follow
igg
product
reach
plateau
week
later
may
persist
year
reinfect
may
result
overproduct
igg
togeth
low
undetect
product
igm
anoth
major
issu
antibodi
measur
type
antibodi
target
test
thu
antibodi
detect
eia
may
differ
confer
neutral
activ
neutral
antibodi
persist
viral
infect
measur
aim
determin
vaccin
efficaci
use
epidemiolog
studi
rather
diagnosi
primari
infect
neutral
antibodi
rais
particular
epitop
usual
found
surfac
viru
bind
viru
render
noninfecti
block
attach
receptor
prevent
uncoat
viru
test
assess
neutral
antibodi
serum
sampl
usual
incub
viral
prepar
known
titer
abil
inhibit
tcid
cpe
develop
cell
cultur
assess
altern
reduct
abil
viral
prepar
form
plaqu
measur
three
main
way
detect
respiratori
viru
host
serolog
immunoassay
conduct
manner
similar
describ
earlier
detect
viral
antigen
directli
measur
antibodyviru
interact
use
label
reagent
complement
fixat
passiv
agglutin
assay
base
abil
virusantibodi
interact
interfer
function
discuss
earlier
allow
differenti
antibodi
class
final
assay
hemagglutin
inhibit
allow
measur
particular
antibodi
specif
interact
viral
surfac
protein
antigen
detect
immunoassay
describ
earlier
report
molecul
conjug
antibodi
antigen
allow
assess
virusantibodi
interact
report
molecul
may
fluoresc
immunofluoresc
may
enzymat
activ
colordevelop
substrat
eia
may
radioact
ria
immunofluoresc
assay
purifi
hyperimmun
anim
sera
monoclon
antibodi
label
fluoresc
dye
eg
fluorescein
isothiocyan
typic
protocol
serum
sampl
incub
virusinfect
cell
fix
slide
unbound
materi
wash
slide
dri
mount
observ
fluoresc
microscop
streptavidinbiotin
similar
system
current
use
provid
greater
flexibl
sensit
antibodi
detect
background
fluoresc
common
obstacl
immunofluoresc
procedur
solidphas
fluoroimmunoassay
viral
antigen
immobil
opaqu
solidphas
surfac
rather
slide
fluoresc
measur
fluoromet
allow
quantit
autom
method
howev
fluoroimmunoassay
instrument
discrimin
background
posit
fluoresc
enzym
immunoassay
use
detect
quantit
antibodi
rais
viral
antigen
antigen
obtain
variou
sourc
lysat
virusinfect
cell
end
cell
wash
resuspend
serumfre
medium
subject
repeat
freezethaw
cycl
viru
clarifi
ultracentrifug
provid
rich
sourc
antigen
synthet
peptid
also
may
use
antigen
prepar
indirect
eia
antigen
bound
solidphas
surfac
incub
serum
sampl
bound
antibodi
detect
antihuman
antibodi
enzym
conjug
abund
igg
antibodi
compet
antigen
class
thu
remov
igm
measur
nonspecif
bind
common
method
impur
present
antigen
prepar
may
caus
falseposit
result
preincub
sera
uninfect
cell
may
reduc
problem
increas
specif
method
inhibit
competit
eia
use
case
serum
antibodi
detect
abil
block
bind
known
antibodi
conjug
antigen
detector
antibodi
ad
simultan
antigen
serum
sampl
falseneg
result
caus
case
serum
antibodi
compet
conjug
antibodi
inhibit
abil
antibodi
test
captur
eia
method
antihuman
immunoglobulin
classspecif
antibodi
first
bound
solidphas
capturephas
surfac
incub
serum
sampl
viral
antibodi
bound
captur
phase
togeth
viralunrel
antibodi
viral
antigen
ad
last
subsequ
detect
antigenspecif
antibodi
conjug
due
select
classspecif
adsorpt
first
step
method
avoid
problem
caus
competit
antibodi
class
particularli
improv
igm
detect
hand
lowlevel
igg
detect
may
less
sensit
due
presenc
larg
quantiti
total
igg
antibodi
serum
necessari
detect
low
level
virusspecif
antibodi
serum
standard
immunoblot
techniqu
western
blot
use
briefli
protein
content
semipurifi
viru
propag
cell
cultur
appli
onto
nondenatur
polyacrylamid
gel
electrophoret
separ
protein
band
transfer
nitrocellulos
nylon
membran
cut
narrow
strip
store
freezer
serum
sampl
dilut
buffer
contain
protein
block
free
bind
site
reduc
nonspecif
bind
incub
membran
wash
step
bound
antibodi
measur
use
radioact
enzymelabel
conjug
bound
suitabl
secondari
antibodi
dot
immunobind
assay
viral
antigen
bound
dot
membran
membran
treat
potenti
proteinbind
site
remain
membran
block
dot
cover
small
eg
strip
satur
test
serum
wash
step
antihuman
igg
conjug
appropri
enzym
ad
follow
incub
appropri
chromogen
substrat
intens
color
spot
compar
produc
control
sera
reveal
specif
antivir
antibodi
dot
immunobind
assay
serv
qualit
rather
quantit
assay
also
subject
problem
nonspecif
bind
radioimmunoprecipit
assay
antigenantibodi
complex
form
incub
serum
test
viral
antigen
crosslink
immunoprecipit
protein
antihuman
igg
antibodi
quantiti
radioact
bound
precipit
measur
proport
concentr
specif
antibodi
serum
avid
assay
measur
rel
degre
dissoci
specif
antivir
antibodi
respect
antigen
matur
immun
respons
avid
strength
combin
interact
antiserum
pattern
antigen
igg
antibodi
remain
high
wherea
concentr
declin
thu
sera
recent
infect
character
highavid
antibodi
sera
reinfect
lowavid
antibodi
practic
serum
incub
first
antigen
bound
solidphas
surfac
complex
allow
dissoci
presenc
absenc
urea
rel
degre
antibodi
dissoci
ratio
absorb
presenc
urea
absorb
absenc
urea
measur
standard
eia
method
final
three
type
method
use
specif
measur
igm
antibodi
typic
transient
express
primari
infect
may
facilit
identif
first
igg
absorpt
method
igg
absorb
eg
staphylococc
protein
streptococc
protein
g
incub
serum
centrifug
step
igm
antibodi
measur
supernat
absorb
believ
superior
antihuman
igg
antibodi
method
latter
may
also
remov
type
igm
howev
staphylococc
protein
bind
could
interfer
accuraci
method
viral
antibodi
may
significantli
repres
subclass
streptococc
protein
g
hand
bind
igg
subclass
igm
accordingli
combin
streptococci
protein
use
remov
igg
iga
serum
sampl
igm
measur
iga
interfer
igm
measur
result
falseneg
find
compet
igm
antigen
site
second
one
earli
igm
separ
method
rate
zonal
centrifug
allow
purif
igm
subclass
base
higher
sediment
coeffici
compar
antibodi
class
gel
filtrat
take
advantag
higher
molecular
weight
igm
compar
class
vs
kd
howev
serum
lipoprotein
nonspecif
cell
agglutinin
may
fraction
togeth
igm
could
interfer
assay
ionexchang
chromatographi
base
differenti
bind
igm
igg
class
anionexchang
resin
use
igm
yield
rel
low
wherea
igg
iga
may
still
present
igm
fraction
elut
column
third
popular
igm
immunoassay
antihuman
igmspecif
antibodi
employ
indirect
immunofluoresc
eia
method
typic
use
igm
detect
captur
igm
assay
show
reduc
nonspecif
bind
method
solidphas
fix
antihuman
igm
antibodi
separ
igm
incub
serum
sampl
potenti
presenc
antivir
element
detect
use
label
viral
antigen
unlabel
antigen
follow
label
antigenspecif
antibodi
detect
antiparainfluenza
igm
also
report
use
hemadsorpt
complement
fixat
system
take
advantag
fact
complement
protein
bind
fix
antigenantibodi
complex
host
immun
respons
foreign
antigen
antigen
cell
local
deposit
complement
element
caus
cell
lysi
complement
fixat
igm
stronger
timesantibodi
molecul
igg
complement
fixat
antibodi
rais
viral
protein
titer
increas
slowli
primari
infect
reach
lower
level
antibodi
titer
detect
method
addit
declin
gradual
make
method
less
sensit
other
detect
viral
infect
addit
problem
interfer
serum
element
heparin
igg
aggreg
complement
format
typic
complement
fixat
assay
serum
sampl
incub
particular
antigen
presenc
known
amount
guinea
pig
complement
specif
antibodi
present
serum
complement
bound
deplet
solut
subsequ
sheep
erythrocyt
coat
hemolysin
antisheep
erythrocyt
antibodi
ad
lysi
proport
avail
complement
protein
react
specif
antibodi
first
step
howev
complement
fixat
assay
consid
less
sensit
viru
isol
antigen
detect
method
reveal
presenc
respiratori
viru
patient
immun
adher
agglutin
assay
rapid
sensit
variat
aggreg
rather
lysi
erythrocyt
occur
measur
detect
method
complement
bound
antigenantibodi
complex
allow
bind
receptor
human
primat
erythrocyt
thu
agglutin
erythrocyt
reveal
specif
antibodi
sampl
simpl
techniqu
use
earlier
detect
hemagglutin
activitycontain
virus
influenza
parainfluenza
hemolysisingel
test
erythrocyt
sheep
chicken
first
sensit
coupl
viral
antigen
chromium
chlorid
solut
wash
step
erythrocyt
suspend
agaros
gel
contain
guinea
pig
complement
serum
sampl
load
onto
well
gel
allow
diffus
presenc
antibodi
viru
would
lead
format
zone
hemolysi
around
well
anticompl
antifluoresc
modifi
immunofluoresc
assay
detect
complement
fixat
antibodi
assay
complement
ad
exposur
virusinfect
cell
serum
test
complement
bound
detect
antibodi
nonspecif
bound
igg
trigger
complement
fixat
anticompl
antifluoresc
assay
common
background
problem
associ
convent
immunofluoresc
hemagglutinin
hemagglutininneuraminidas
protein
express
envelop
virus
influenza
parainfluenza
abl
bind
specif
erythrocyt
surfac
receptor
caus
agglutin
practic
erythrocyt
crosslink
lead
observ
cell
clump
hemagglutin
inhibit
test
measur
presenc
specif
antibodi
sera
inhibit
virusmedi
agglutin
erythrocyt
sensit
assay
affect
howev
nonspecif
hemagglutinin
agglutinin
inhibitor
present
serum
nevertheless
particularli
reliabl
method
influenza
surveil
protocol
fusion
protein
present
envelop
virus
parainfluenza
rsv
allow
entri
cell
trigger
fusion
viral
surfac
cell
surfac
membran
case
erythrocyt
fusion
may
lead
hemolysi
hemolysi
inhibit
assay
take
advantag
properti
measur
presenc
antibodi
serum
sampl
bind
block
viral
antigen
inhibit
hemolysi
way
hemolysi
inhibit
assay
detect
antihemagglutinin
antifus
antibodi
serum
typic
protocol
serum
dilut
mix
incub
purifi
viru
suspens
suitabl
erythrocyt
ad
hour
incub
erythrocyt
remov
centrifug
optic
densiti
clear
supernat
read
spectrophotomet
classic
endpoint
titer
calcul
defin
highest
serum
dilut
caus
inhibit
hemolysi
passiv
agglutin
assay
sera
incub
viral
antigen
attach
erythrocyt
materi
latex
bentonit
particl
cell
agglutin
presenc
specif
antibodi
form
precipit
bottom
tube
passiv
hemagglutin
method
aggreg
erythrocyt
develop
due
antibodi
bridg
form
antigenco
erythrocyt
visibl
even
nake
eye
may
detect
low
level
antibodi
constel
method
gain
increas
attent
recent
year
due
increas
sensit
eas
use
accuraci
genet
materialbas
method
pcr
lead
posit
common
element
method
isol
partial
purif
viral
rna
dna
subsequ
detect
analysi
suitabl
molecular
biolog
system
hybridizationbas
protocol
requir
presenc
singlestrand
rna
dna
major
respiratori
virus
singlestrand
rna
virus
believ
suitabl
detect
hybrid
techniqu
approach
suitabl
oligonucleotid
probe
share
certain
degre
homolog
allow
base
pair
match
singlestrand
viral
nucleic
acid
allow
anneal
stringent
reaction
condit
hybrid
wherea
singlestrand
rna
virus
provid
readymad
yet
labil
genet
materi
doublestrand
dna
content
adenoviru
must
first
denatur
dissoci
chemic
eg
sodium
hydroxid
physic
heat
mean
result
singlestrand
dna
would
return
doublestrand
configur
remov
dissoci
agent
probe
label
directli
enzym
report
molecul
altern
linker
moieti
biotin
digoxigenin
attach
probe
serv
bridg
attach
report
molecul
digoxigeninlabel
probe
believ
sensit
situ
hybrid
use
biotinstreptavidin
system
typic
protocol
viral
nucleic
acid
isol
purifi
denatur
bound
nitrocellulos
nylon
membran
probe
denatur
label
incub
viral
nucleic
acid
care
defin
condit
unbound
materi
thoroughli
wash
report
molecul
ad
eg
alkalin
phosphataselabel
streptavidin
second
incub
period
unbound
report
wash
final
chromogen
suitabl
substrat
ad
give
rise
measur
signal
sever
hybridizationbas
techniqu
use
viral
nucleic
acid
detect
molecular
biolog
dotblot
southern
blot
protocol
liquid
situ
hybrid
suggest
name
liquid
hybrid
allow
detect
nucleic
acid
free
solut
rather
attach
solidphas
surfac
microtit
plate
strip
use
method
increas
eas
handl
situ
hybrid
allow
detect
viru
varieti
sourc
includ
cell
tissu
grown
fix
slide
respect
rna
hybrid
prove
sensit
method
detect
influenza
replic
cultur
clearli
superior
hemagglutin
assay
show
high
sensit
detect
rna
virus
detect
limit
copi
viral
genomecel
exampl
situ
hybridizationbas
detect
rv
shown
biopsi
specimen
human
bronchi
fig
case
hybrid
superior
even
pcr
detect
respiratori
viru
airway
hybrid
techniqu
also
use
combin
pcrbase
method
increas
overal
sensit
respiratori
viru
detect
protocol
polymeras
chain
reaction
method
allow
specif
amplif
defin
dna
sequenc
subsequ
detect
assess
becom
common
practic
detect
protocol
last
year
section
discuss
recent
innov
field
describ
pcr
basic
detail
mani
exist
handbook
describ
method
major
respiratori
virus
rna
virus
therefor
revers
transcript
pcr
requir
detect
clinic
sampl
first
total
rna
extract
npa
sampl
throat
swab
standard
molecular
biolog
techniqu
sampl
kept
c
avoid
deterior
genet
materi
good
practic
store
sampl
c
appropri
viru
transport
medium
eg
hank
balanc
salt
solut
enrich
bovin
serum
albumin
throat
swab
sourc
place
directli
denatur
solut
inactiv
ribonucleas
enzym
activ
store
transport
room
temperatur
extract
rna
revers
transcrib
complementari
dna
cdna
eg
revers
transcriptas
isol
retroviru
murin
momulv
amplifi
pcr
use
virusspecif
oligonucleotid
primer
design
aid
comput
softwar
primer
usual
plan
amplifi
sequenc
base
pair
long
amplicon
design
discrimin
differ
serotyp
viru
nucleotid
divers
frequent
observ
among
differ
strain
given
viru
speci
also
taken
account
area
high
homolog
select
serotypespecif
primer
pair
design
amplicon
electrophores
agaros
gel
visual
dna
band
ultraviolet
transillumin
stain
ethidium
bromid
anoth
dna
dye
readili
accomplish
within
work
day
fact
particular
import
clinic
diagnost
laboratori
improv
specif
sensit
test
amplicon
hybrid
label
synthes
dna
probe
direct
region
amplicon
instanc
southern
blot
success
use
identif
picornavirus
altern
revers
transcriptas
pcr
combin
eia
techniqu
consist
hybrid
amplicon
biotinyl
rna
probe
direct
intern
sequenc
amplicon
timeresolv
fluorometri
also
combin
pcr
detect
picornavirus
pcr
amplicon
also
use
sourc
second
round
pcr
nest
pcr
usual
show
increas
sensit
approach
second
set
primer
design
sequenc
local
intern
sequenc
amplifi
first
round
method
sensit
detect
particl
respiratori
viru
nestedtyp
pcr
may
increas
sensit
also
may
discrimin
serotyp
within
viral
speci
similar
size
thu
difficult
separ
gel
first
round
pcr
discrimin
within
speci
also
accomplish
digest
amplicon
restrict
endonucleas
human
rv
instanc
discrimin
enterovirus
base
specif
pattern
produc
digest
pcr
product
bgli
restrict
endonucleas
enterovirus
lack
bgli
recognit
site
respect
amplifi
sequenc
thu
product
remain
undigest
retain
origin
size
fig
multiplex
pcr
mix
primer
pair
use
allow
simultan
amplif
detect
sever
serotyp
virus
mani
exampl
literatur
formul
hexaplex
prodess
waukesha
wisconsin
instanc
allow
detect
influenza
influenza
b
rsv
subtyp
three
four
human
parainfluenza
multiplex
pcr
test
clinic
sampl
seem
achiev
high
rate
sensit
specif
addit
highli
sensit
rapid
type
test
allow
simultan
detect
mani
virus
provid
obviou
advantag
clinic
practic
also
may
reveal
presenc
viru
sampl
viral
copi
presenc
viral
rna
without
live
viru
may
miss
convent
cell
cultur
techniqu
detect
limit
multiplex
revers
transcriptas
pcr
protocol
allow
identif
copi
virusml
one
tcid
method
least
sensit
combin
tissu
cultur
immunofluoresc
method
combin
hybrid
may
improv
detect
score
combin
multiplex
revers
transcriptas
pcr
enzym
hybrid
assay
amplicon
seven
respiratori
virus
rsv
b
influenza
b
parainfluenza
virus
purifi
hybrid
peroxidaselabel
probe
avidinco
micropl
signal
emit
incub
complex
substrat
allow
detect
almost
twice
mani
posit
clinic
sampl
compar
convent
cultur
indirect
immunofluoresc
method
perform
multiplex
pcr
assay
may
vari
depend
viru
test
instanc
multiplex
pcr
enzymelink
immunosorb
assay
detect
seven
respiratori
virus
addit
common
respiratori
pathogen
mycoplasma
pneumonia
chlamydia
pneumonia
although
prove
sensit
cell
cultur
detect
parainfluenza
viru
adenoviru
influenza
viru
less
effici
least
factor
reveal
rsv
parainfluenza
viru
recent
develop
method
includ
primer
specif
addit
viral
bacteri
speci
eg
reoviru
bordetella
pertussi
allow
detect
mani
differ
microorgan
clinic
sampl
final
multiplex
pcr
assay
design
discrimin
multipl
subtyp
within
one
speci
case
adenovirus
picornavirus
anoth
approach
degener
primer
use
discrimin
adenoviru
serotyp
amplicon
also
subject
sequenc
analysi
identifi
potenti
point
mutat
delet
specif
serotyp
clone
pcr
fragment
gener
seri
partial
overlap
degener
primer
bacteri
plasmid
allow
sequenc
entir
viral
genom
labori
activ
necessari
usual
clinic
practic
indispens
previous
unknown
viral
speci
character
eg
mpv
highrisk
epidem
initi
unknown
viral
strain
mutat
must
confront
effici
quickli
eg
sar
heteroduplex
format
amplicon
may
result
differenti
mobil
product
run
gel
use
subtyp
viral
genom
combin
instanc
revers
transcriptas
pcr
heteroduplex
format
variant
strain
influenza
differenti
situ
pcr
allow
detect
viral
genet
materi
furthermor
local
cellular
tissu
level
provid
inform
particular
import
clinic
patholog
thu
paraffinembed
fix
cell
tissu
section
xylenetr
digest
proteas
deoxyribonucleas
solut
pcr
mixtur
contain
taq
polymeras
place
top
entir
slide
place
aluminium
foil
boat
transfer
onto
convent
modifi
pcr
apparatu
subject
pcr
amplif
one
four
deoxynucleosid
dntp
present
pcr
mixtur
provid
nucleotid
sourc
reduc
replac
modifi
nucleotid
eg
biotinyl
digoxigenincoupl
deoxyuridin
emerg
amplicon
detect
incub
enzymelabel
probe
eg
alkalin
phosphatas
antidigoxigenin
altern
absenc
modifi
nucleotid
amplifi
dna
detect
convent
situ
hybrid
conduct
describ
earlier
altern
pcr
mixtur
transfer
test
tube
run
agaros
gel
subject
southern
analysi
identifi
viral
genom
fragment
recent
advanc
pcr
technolog
allow
develop
realtim
pcr
realtim
pcr
sensit
timeeffici
convent
pcr
cell
cultur
immunofluoresc
detect
respiratori
virus
clinic
sampl
quantit
allow
assess
exact
number
viral
copi
clinic
sampl
particular
import
case
actual
viral
load
may
determin
cours
diseas
final
detect
step
employ
either
dye
abl
bind
doublestrand
dna
eg
sybr
green
specif
hybrid
probe
eg
taqman
molecular
beacon
light
cycler
probe
monitor
presenc
quantiti
amplicon
quantit
analysi
well
determin
detect
limit
serial
dilut
plasmid
dna
contain
known
amount
viral
genom
viru
genom
equival
per
microlit
use
standard
refer
solut
fluoresc
dye
sybr
green
protocol
dye
incorpor
amplicon
cycl
assess
fluoresc
dna
collect
extens
phase
howev
dye
bind
dna
independ
specif
sequenc
thu
also
detect
undesir
nonspecif
amplifi
dna
thu
specif
method
test
melt
curv
final
amplicon
briefli
heat
denatur
eg
c
allow
reassoci
lower
temperatur
eg
c
second
final
redenatur
c
gradual
increas
temperatur
defin
rate
eg
csec
continu
measur
fluoresc
data
record
last
stage
plot
temperatur
allow
calcul
melt
peak
character
given
amplicon
condit
use
melt
peak
particular
product
coincid
standard
consid
specif
highli
sensit
oneand
twostep
realtim
pcr
assay
qualit
quantit
detect
respiratori
virus
includ
sarscov
report
hybridizationbas
protocol
specif
probe
share
consensu
homolog
sequenc
strain
viral
speci
label
report
fluorogen
dye
eg
end
quencher
dye
eg
carboxytetramethylrhodamin
end
probe
present
convent
pcr
master
mix
contain
buffer
magnesium
salt
dntp
water
primer
pcr
realtim
apparatu
record
fluoresc
emerg
time
report
dye
fluoresc
eg
consid
posit
compar
fluoresc
emit
refer
dye
present
pcr
master
mix
normal
nonpcrrel
fluoresc
fluctuat
among
sampl
threshold
usual
set
signal
consid
posit
recent
approach
detect
respiratori
virus
includ
develop
multiplex
realtim
pcr
protocol
sybr
greenbas
reaction
instanc
allow
simultan
detect
influenza
b
togeth
rsv
specif
compar
achiev
commerci
avail
rapid
antigen
test
consider
higher
sensit
score
discrimin
particular
speci
base
specif
melt
temperatur
curv
elicit
amplicon
method
howev
design
discrimin
b
subtyp
rsv
limit
number
virus
viral
serotyp
inher
realtim
approach
especi
protocol
use
label
probe
platform
allow
simultan
use
two
fluorochrom
use
advanc
apparatu
detect
four
fluorochrom
templeton
colleagu
succeed
detect
influenza
serotyp
rsv
four
parainfluenza
subtyp
twotub
reaction
approach
specif
probe
label
differ
fluorochrom
ie
texa
red
hexachlorofluoroscein
cyanin
overal
reaction
could
accomplish
within
hour
prove
sensit
cell
cultur
detect
seven
respiratori
virus
clinic
sampl
detect
limit
rang
tcid
viral
stock
known
titer
depend
viru
advanc
molecular
biolog
continu
offer
addit
pcrand
hybridizationbas
method
recent
studi
rna
copi
parainfluenza
viru
one
could
detect
probe
hybrid
electrochemiluminesc
use
molecular
beacon
first
step
approach
nucleic
acid
sequencebas
amplif
use
techniqu
employ
avian
myeloblastosi
viru
revers
transcriptas
togeth
ribonucleas
h
rna
polymeras
isotherm
condit
abl
directli
amplifi
rna
use
nucleic
acid
sequenc
amplifi
rna
primer
direct
noncod
region
rv
serotyp
allow
discrimin
rv
subgroup
complementari
dnaamplifi
restrict
fragment
length
polymorph
allow
identif
previous
unknown
viral
sequenc
method
doublestrand
cdna
synthes
viral
rna
digest
frequent
cut
restrict
endonucleas
doublestrand
adaptor
ligat
end
emerg
restrict
fragment
provid
primer
site
pcr
amplif
second
select
fragment
amplif
step
conduct
ad
one
base
pcr
primer
complementari
base
present
viral
sequenc
success
amplif
occur
modif
method
success
employ
recent
discoveri
new
coronaviru
recent
wang
colleagu
use
power
microarray
technolog
detect
approxim
distinct
viral
genom
simultan
includ
respiratori
virus
end
oligonucleotid
rel
greater
length
commonli
use
array
technolog
vs
base
select
genomewid
blast
basic
local
align
search
tool
method
rapid
search
nucleotid
protein
databas
analysi
rank
accord
share
homolog
region
viral
genom
use
inkjet
oligonucleotid
synthes
oligonucleotid
synthes
situ
place
onto
direct
locat
glass
wafer
glass
surfac
hybrid
strict
condit
cdna
pcr
amplicon
rna
anoth
form
genet
materi
deriv
viral
stock
viral
infect
cell
cultur
clinic
sampl
human
cellular
transcript
also
includ
normal
nonspecif
hybrid
materi
label
cyanin
cyanin
provid
red
green
color
respect
allow
color
visual
microarray
data
obtain
array
scan
confoc
laser
scanner
analyz
suitabl
instrument
softwar
method
allow
detect
paramyxovirus
orthomyxovirus
adenovirus
picornavirus
clinic
sampl
also
detect
discrimin
among
rv
serotyp
base
hybrid
pattern
obtain
serotyp
human
volunt
experiment
infect
rv
array
could
detect
infecti
rv
particl
npa
sampl
analysi
small
number
sampl
natur
acquir
cold
show
differ
rv
serotyp
parainfluenza
viru
also
confirm
convent
revers
transcriptas
pcr
although
extrem
promis
techniqu
need
evalu
includ
costeffect
appli
clinic
practic
nucleic
acidbas
viru
detect
rapid
accur
identif
particular
viru
without
doubt
confirm
restrict
analysi
sequenc
product
comparison
publish
genom
databas
addit
pcrbase
method
prove
sensit
usual
exceed
sensit
score
cell
cultur
techniqu
howev
falseposit
falseneg
find
problem
method
certain
practic
measur
handl
viral
genet
materi
meticul
follow
first
preserv
sampl
particular
import
integr
viral
genom
materi
rna
genom
materi
respiratori
virus
particularli
vulner
degrad
ribonucleas
present
biolog
sampl
fluid
ribonucleasefre
vial
solut
buffer
use
design
area
laboratori
materi
use
special
personnel
addit
take
long
npa
sampl
transport
clinic
laboratori
sampl
remain
ice
mani
hour
instead
place
freezer
immedi
sensit
method
even
pcrbase
protocol
unexpectedli
low
biolog
fluid
often
contain
substanc
inhibit
pcr
amplif
eg
mucu
case
dilut
sampl
treatment
suitabl
agent
eg
dimethyl
sulfoxid
may
facilit
detect
viru
use
clinic
sampl
spike
stock
viru
inclus
synthet
heterolog
competitor
rna
reaction
may
facilit
normal
pcr
outcom
hand
pcrbase
techniqu
also
subject
problem
contamin
especi
larg
number
sampl
handl
simultan
case
nest
pcr
protocol
first
second
round
pcr
conduct
separ
area
separ
set
pipett
cours
differ
plasticwar
nest
pcr
protocol
includ
sever
neg
control
monitor
presenc
contamin
occur
replac
pipett
requir
well
review
laboratori
handl
practic
respiratori
infect
caus
major
health
problem
huge
associ
cost
mortal
rate
worldwid
addit
threaten
influenza
pandem
mortal
epidem
previous
unknown
respiratori
virus
sarscov
requir
use
rapid
reliabl
detect
method
clinic
practic
moreov
larg
epidemiolog
studi
requir
better
defin
involv
virus
noninfecti
diseas
asthma
short
long
term
analysi
help
drug
develop
implement
intervent
strategi
even
outbreak
mani
respiratori
symptom
common
among
virus
clinic
examin
determin
etiolog
particular
case
hand
drug
develop
specif
block
infect
individu
virus
ie
antiinfluenza
neuraminidas
inhibitor
useless
patient
infect
anoth
viru
thu
method
major
increas
import
use
clinic
practic
possibl
determin
optim
method
viru
detect
mani
paramet
vari
depend
particular
condit
scope
analysi
costeffect
time
requir
sensit
avail
skill
personnel
laboratori
equip
combin
method
rather
singl
one
practic
use
particular
case
protocol
ideal
even
electron
microscopi
still
recogn
indispens
method
case
although
cell
cultur
remain
gold
standard
time
consum
tend
replac
antigendetect
method
molecular
biolog
techniqu
commerci
avail
eas
perform
rapid
made
newli
develop
antigenbas
method
increasingli
popular
actual
test
tend
prefer
routin
analysi
especi
small
unit
lack
advanc
facil
accomplish
within
minut
hour
howev
inferior
cell
cultur
term
sensit
limit
valu
detect
respiratori
virus
rsv
older
popul
group
hand
pcr
wide
use
research
tool
last
decad
clinic
use
steadili
increas
pcr
howev
replac
use
cell
cultur
worldwid
influenza
surveil
aspect
classic
virolog
vital
inform
vaccin
constitu
rapid
high
sensit
specif
eas
use
costeffect
major
requir
impos
respiratori
viral
detect
assay
field
particular
need
rapid
diagnost
like
increas
specif
antivir
therapi
enter
market
mani
wholeviru
antigen
serolog
molecular
method
extens
test
use
clinic
practic
although
pcrbase
analysi
major
breakthrough
recent
year
none
exist
method
consid
ideal
usual
combin
techniqu
use
accur
result
increas
cost
time
skill
requir
analysi
rapid
antigen
detect
test
moment
easiest
appli
expect
improv
futur
electron
microscopi
still
use
mani
case
exampl
crucial
first
screen
character
previous
unknown
sarscov
simultan
reliabl
detect
mani
virus
possibl
shortest
time
possibl
ideal
singl
test
goal
novel
futur
techniqu
although
specif
sensit
reliabl
multiplex
realtim
pcr
detect
limit
number
virus
simultan
may
howev
improv
futur
nevertheless
detect
microorgan
seem
achiev
convent
multiplex
pcr
method
retain
pcr
approach
lead
posit
hand
rapidli
develop
gene
array
field
promis
without
clinic
relev
techniqu
also
combin
assay
reveal
express
pattern
target
gene
host
thu
provid
overal
pictur
viral
presenc
also
host
respons
pattern
could
provid
addit
inform
regard
immedi
effect
specif
treatment
would
obvious
tremend
import
clinic
practic
